Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations
Substance Use and Addiction Journal
This is a narrative review of methadone and buprenorphine regulations, prescriber eligibility, dispensing models, and coverage across eight countries: the United States, Canada, the United Kingdom, Russia, France, Iran, Australia, and Portugal. The study identified several key barriers to MOUD: requirements for daily supervised dosing, restricted community prescribing, and stigmatizing drug scheduling. The authors highlight policies that improved MOUD access without compromising safety such as: 1) community pharmacy dispensing supports in the U.K. and Australia, 2) liberal buprenorphine prescribing in primary care in France, and 3) decriminalization and expansion of low-threshold public health models in Portugal and Iran.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM